Cell of origin role in cancer stem cell and GBM phenotype
Cell of origin role in cancer stem cell and GBM phenotype
New RAF-targeted therapeutic shows early promise against tumours with BRAF and RAS mutations
MINDACT breast cancer clinical trial: First results and impact on future trial design
Breast cancer research news from AACR President Nancy Davidson
BSH 2016: Expert discussion on front line care in CLL
BSH 2016: Expert discussion on idelalisib
Comparison of three different PD-L1 diagnostic tests shows a high degree of concordance
Mutational clonality and intratumour heterogeneity as biomarkers for cancer immunotherapy
Risk of breast cancer after chest radiotherapy may be affected by genetics
Retroviral replicating vectors for cancer-targeted gene therapy and immunotherapy
NY-ESO-1 immunotherapy for ovarian cancer
Imaging tumour habitats - life at the edge